U.S. Auto Stock News

Pony AI (PONY) has just reported Q3 2025 results, posting revenue of $25.4 million and a basic EPS of -$0.16. Over recent quarters, the company’s revenue has moved from $14.0 million in Q1 2025, to $21.5 million in Q2, reaching $25.4 million in the latest period, while EPS has remained negative. Despite consistent revenue gains, margins are still challenged as losses persist, keeping profitability in focus for investors. See our full analysis for Pony AI. Now, let’s see how these reported...

Wondering whether S&P Global is trading at a bargain or if the price is outpacing its true worth? You are definitely not alone, as valuation is top of mind for many investors right now. The stock has shown a mix of performance lately, with a 1.0% gain over the past week, essentially flat year-to-date, and down 4.5% over the last 12 months. It is also up an impressive 55.0% over five years. These price moves have come as the company continues to expand its presence in financial data and...

Cal-Maine Foods (CALM) has been getting attention from investors after it acquired Echo Lake Foods, bringing new prepared food offerings such as omelets and pancakes. With more states requiring cage-free eggs, along with ongoing supply challenges from avian flu, the company’s outlook has shifted in interesting ways. See our latest analysis for Cal-Maine Foods. Momentum has cooled for Cal-Maine Foods in recent months, with the share price sliding 28% over the past quarter despite notable moves...

In the past quarter, Diamond Hill Capital's Small Cap Strategy highlighted United States Lime & Minerals, Inc. as a top contributor, crediting sales growth to heightened demand from construction, environmental, and steel customers in key markets like Louisiana and Texas. An interesting insight is that ongoing infrastructure efforts and strong bidding activity are expected to foster consistently high demand for the company's products in these regions. We'll explore how robust infrastructure...

The emergence of a bullish hammer chart pattern in Everus Construction Group (ECG) has caught investor attention, as it points to a potential shift in momentum following a stretch of bearish trading. Recent revisions in earnings estimates further highlight shifting expectations for the company. See our latest analysis for Everus Construction Group. Everus Construction Group’s 30.9% share price return year-to-date shows momentum is building. The latest bullish pattern and higher earnings...

In the past week, Atlassian reported better-than-expected fiscal first quarter 2026 results, highlighted by strong cloud revenue growth and increased product adoption, while also announcing it had acquired developer intelligence firm DX and launched a US$2.5 billion share repurchase program. Despite these positives, Atlassian lowered its full-year billings guidance, raising questions about the pace and consistency of its longer-term growth trajectory. We will explore how Atlassian’s cautious...

Devon Energy (DVN) has drawn fresh attention from investors after Goldman Sachs reiterated its “Buy” rating. This follows the company’s Q3 2025 results and new guidance, which offers insight into next year’s strategy. See our latest analysis for Devon Energy. After a stretch of volatility, Devon Energy’s share price has rebounded with a 10% climb over the last month, setting a positive tone amid cautious optimism. However, momentum remains mixed, as its total shareholder return is down 1% in...

Wondering if Ameriprise Financial stock is still a smart place for your money? Let's take a closer look at what makes it stand out on a value basis. The share price closed at $453.47, delivering a steady 0.8% gain in the past week. However, it remains down 6.4% over the last month and 14.4% year-to-date, so there has been real movement for investors to consider. Recent headlines have drawn attention to Ameriprise Financial’s evolving strategy in wealth management and the growing demand for...

Sysco (SYY) has announced that Greg Bertrand, its Executive Vice President and Global Chief Operating Officer, will transition to a non-executive advisor role starting January 2026 as he prepares for retirement. Leadership changes at this level often prompt investors to take a closer look at the company’s future direction and strategic plans. See our latest analysis for Sysco. Sysco’s leadership update has come amid a relatively steady period for the share price, which currently sits at...

Earlier this month, Morgan Stanley analyst Devin McDermott highlighted EQT Corporation's quarterly free cash flow of US$484 million, noting its strong production, record-low cash costs, and a 5% increase in base dividend. An important insight is EQT's outlook for substantial free cash flow over the next five years, underpinned by anticipated utility demand growth and a paced LNG strategy. We'll explore how EQT's robust free cash flow and dividend increase could reinforce its investment...

Thinking about whether Moelis is a bargain or overpriced? You are not alone, and there are a few ways to look at its underlying value before making your next move. Moelis shares have recently swung higher, up 4.8% over the last week, but still sit down 11.8% over the past year and 13.4% year-to-date. This makes for a mixed recent performance story. News that Moelis is expanding its advisory presence in new markets has caught investor attention and could be a factor in the recent price...

Curious if IAC might be a diamond in the rough or just another tech name on the Nasdaq? Let's break down what's been happening with its stock and why the valuation debate has never been more interesting. Over the past week, IAC’s share price has jumped 8.2%, building on a modest 2.9% rise over the past month. The stock is still trailing with a -18.8% return year-to-date. Investors took notice of IAC recently after news emerged about potential strategic moves within its media portfolio, as...

If you have ever wondered whether Neurocrine Biosciences deserves a spot in your portfolio, you are not alone. Figuring out its fair value is where smart investing starts. The stock recently climbed 9.8% in just the past week and has delivered a solid 19.7% return over the last twelve months, catching the eye of growth-minded investors. This momentum has been fueled by increased attention on Neurocrine’s innovative therapies and positive updates on pipeline developments, with recent industry...

Texas Pacific Land (TPL) reported third-quarter 2025 results that came in below expectations for both earnings and revenue. Still, the stock drew attention in premarket trading and prompted fresh consideration of the company’s current valuation. See our latest analysis for Texas Pacific Land. Texas Pacific Land’s share price has faced heavy pressure this year, with a year-to-date decline of almost 27% and a sharp 47% dip in the total shareholder return over the past twelve months. While the...

The Bonds Flying Roos recently announced that monday.com has joined as their Official Global Work Management Partner through a multi-year agreement, with the partnership debuting at the Abu Dhabi Grand Final of SailGP in November 2025. This collaboration is set to centralize and streamline the team’s operations on monday.com’s AI-powered platform, supporting their global logistics and aiming to enhance performance both on and off the water. We'll explore how monday.com's new partnership with...

Wondering if AllianceBernstein Holding is undervalued, fairly priced, or perhaps even hiding in plain sight as an opportunity? You are not alone, and we are about to break down exactly what investors should know. The stock is up 4.3% over the last week and 22.5% in the past year, showing that the market has recently warmed up to its potential, whether for growth or shifting risk expectations. Recent headlines have kept AllianceBernstein in the spotlight, from analyst upgrades to industry...

In the past week, ACI Worldwide presented at both Citi's 14th Annual FinTech Conference in New York and Stephens Annual Investment Conference in Nashville, sharing insights on payment technology trends. A unique highlight from these events was ACI Worldwide’s warning that retailers could see a 25% increase in 'friendly fraud' between Thanksgiving and Cyber Monday, and the promotion of its AI-powered solutions to help merchants manage this growing risk. To understand how these developments...

The Connecticut Public Utilities Regulatory Authority recently rejected Eversource Energy’s (NYSE:ES) proposed sale of Aquarion Water, adding fresh uncertainty to its financial plans. At the same time, a brokerage upgrade has sparked new interest in the stock. See our latest analysis for Eversource Energy. The regulatory setback in Connecticut and renewed optimism from Janney’s upgrade have stirred noticeable market action for Eversource. The share price has bounced back over 3% in the past...

Curious whether Digital Realty Trust is a deal or overpriced? You are not alone in wondering if now is the right time to buy, hold, or walk away. The stock has seen a tumultuous ride recently, dropping 10.8% over the past month and 16.2% over the past year, even as it reported a 57.1% return over three years. Much of this volatility has been fueled by shifting sentiment across the real estate and data center sectors, with investor attention focusing on Digital Realty’s role in powering the...

Ever wondered if Humana stock is a hidden gem, overpriced, or sitting somewhere in between? Many investors are searching for clues in its recent moves. After a 7.5% gain over the past week, Humana shares are still down 15.9% over the last month and 2.6% year-to-date. This points to both volatility and shifting investor sentiment. Several headlines have added fuel to the fire for Humana's recent price swings. The healthcare insurer has been expanding its Medicare Advantage plans and...

Earlier this week, Pacira BioSciences filed patent infringement lawsuits against The WhiteOak Group and Qilu Pharmaceutical over their proposed generic versions of EXPAREL, triggering a 30-month stay on FDA approval for these generics under the Hatch-Waxman Act. This legal action helps protect Pacira’s core product, EXPAREL, by postponing generic competition and extending its market exclusivity period. We’ll explore how this delay in generic competition for EXPAREL could influence the...

W. P. Carey (WPC) continues to attract attention from yield-seeking investors, as the company demonstrates steady performance and maintains a focus on diversified net lease real estate across the U.S. and Europe. Shares have drifted slightly higher over the past month, adding just over 0.8%, while the broader real estate sector adjusts to current market conditions. See our latest analysis for W. P. Carey. W. P. Carey’s share price momentum has cooled after a strong first half of the year, but...

Norwegian Cruise Line Holdings (NCLH) caught investor attention this week as shares posted mixed moves. The stock retreated around 22% over the past month. The cruise operator continues navigating shifting travel demand and market headwinds. See our latest analysis for Norwegian Cruise Line Holdings. After a challenging stretch, Norwegian Cruise Line Holdings’ recent 1-month share price return of -22% only adds to its year-to-date slump. This reflects fading momentum as travelers and...

Despite a 36% gain in Pacific Biosciences of California, Inc.'s ( NASDAQ:PACB ) stock price this week, shareholders...